PharmaCyte Biotech, Inc. · NASDAQ:PMCB
PharmaCyte Biotech, Inc. shareholders
As of Sep 30, 2026, 24 institutions reported holding PharmaCyte Biotech, Inc., 6.3% of its shares. Largest: Citadel, Geode Capital and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of PharmaCyte Biotech, Inc. | Change | Filed |
|---|---|---|---|---|
| Citadel | 140K | 1.3% | −143K | Nov 16, 2026 |
| Geode Capital | 124K | 1.2% | −313 | Nov 6, 2026 |
| Vanguard | 80,230 | 0.75% | no change | Nov 13, 2026 |
| Renaissance Technologies | 64,738 | 0.60% | +26,751 | Nov 12, 2026 |
| Jane Street | 64,153 | 0.60% | +34,089 | Nov 12, 2026 |
| Northern Trust | 32,624 | 0.30% | no change | Nov 16, 2026 |
| XTX Topco Ltd | 30,386 | 0.28% | −3,794 | Nov 16, 2026 |
| Susquehanna | 30,063 | 0.28% | −14,790 | Nov 16, 2026 |
| StoneX Group Inc. | 30,006 | 0.28% | new | Nov 3, 2026 |
| Schonfeld Strategic Advisors LLC | 26,247 | 0.24% | −679 | Nov 16, 2026 |